Buscar resultados de ensayos clínicos
Clear Cell Renal Cell Carcinoma - 29 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer Condición:
Fecha: 2008-08-01 Intervenciones: |
Completed |
Nombre del estudio: Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma Condición: Clear Cell Renal Cell Carcinoma Fecha: 2005-09-12 Intervenciones:
|
Recruiting |
Nombre del estudio: Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer Condición:
Fecha: 2012-08-24 Intervenciones: |
Not yet recruiting |
Nombre del estudio: Study to Evaluate Efficacy and Safety of Sunitinib in Patients With Renal Cell Carcinoma Who Have Progressed to First-line Immunotherapy Treatment Condición: Clear Cell Renal Carcinoma Fecha: 2017-02-23 Intervenciones: Drug: Sunitinib Sunitinib 50 mg/d |
Recruiting |
Nombre del estudio: A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma Condición:
|
Recruiting |
Nombre del estudio: Trial of X4P-001 in Patients With Advanced Renal Cell Carcinoma Condición: Clear Cell Renal Cell Carcinoma Fecha: 2016-01-20 Intervenciones:
|
Completed |
Nombre del estudio: Investigating Patient Satisfaction With Oral Anti-Cancer Treatment Condición: Clear Cell Renal Cell Carcinoma Fecha: 2014-07-03 |
Completed |
Nombre del estudio: Value of Various Chemokines in the Detection and Follow up of RCC Condición: Clear Cell Renal Cell Carcinoma Fecha: 2013-10-30 Intervenciones: Other: patients with renal cell carcinoma Chemokines that may be elevated in patients with RCC |
Completed |
Nombre del estudio: 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC Condición: Clear Cell Renal Cell Carcinoma Fecha: 2013-01-08 Intervenciones: Drug: Dovitinib Patients will be treated with dovitinib (5 |
Completed |
Nombre del estudio: Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer Condición: Metastatic Clear Cell Renal Cell Carcinoma Fecha: 2013-11-29 Intervenciones: Drug: Lu-177-DOTA-girentuximab Drug: In-111-DOTA-girentuxi |